Vygon appoints new general manager to lead UK subsidiary

Ecouen, France, January 7, 2026 – Vygon, a leading group specialized in the design, manufacturing and marketing of medical devices in neonatology and vascular management clinical specialties, today announces the appointment of Dale Keegan as general manager of the group’s UK subsidiary, effective since January 1, 2026.

Keegan has been with the company since August 2016 and was chief financial officer until the end of 2025. In this position, he has played a key role in implementing financial strategy, managing HR operations, and ensuring operational efficiency and sustainable growth.

In his new role as general manager, Keegan will ensure that the UK subsidiary sees sustainable growth, while remaining compliant and aligned with the Group’s strategy and values. He will achieve these goals through strategic and commercial leadership, including driving growth across the NHS and the private sector, managing teams and overseeing financial activity, as well as maintaining compliance and ESG requirements.

Keegan replaces Les Davies who will manage the development of Vygon’s principal markets.

“I’m delighted to take on this new role as general manager of Vygon UK,” said Dale Keegan. “There is a growing need for innovative and high-quality medical devices. Thanks to our complete portfolio and comprehensive expertise, I’m confident we can pursue our mission: to help clinicians deliver the best possible outcomes for their patients through the unmatched quality of our products and our constant innovation to improve and save lives.”

“I would like to thank Les Davies for managing Vygon UK over the past 20 years and turning it into a strategic subsidiary for the Vygon Group,” said Ludovic Richard-Vitton, CEO at Vygon. “We congratulate Dale Keegan on his promotion. His strong industry knowledge and leadership skills will help us enter a new phase of growth and innovation in the UK market.”

Vygon UK is a leading supplier of single-use medical and surgical devices, part of the Vygon Group. Opened in 1973, this subsidiary is a key provider of intravenous access devices to the NHS and private sector within the UK market, supplying leading brand names such as Multicath, Lifecath, Leadercath, Bionector, Vadsite and Nutrisafe2. Its diverse product range includes PICCs, neonatal nasogastric feeding tubes and vascular access products, with numerous other solutions available across its clinical portfolio. The company also provides dedicated technical support, comprehensive training and education.

About Vygon

Vygon designs, manufactures and markets single-use medical devices for healthcare professionals in hospitals and for private and independent practitioners. A world leader in the neonatology and vascular management clinical specialties, the company also offers a wide range of products in hemodynamic management, adult enteral nutrition, airways management and loco-regional anesthesia. Vygon combines local and international in-depth expertise and know-how in each individual field. It recently entered the market for active medical devices which require a power source.

With expertise across the entire value chain, from product design to the delivery of training for medical personnel, Vygon provides healthcare professionals with effective and innovative products tailored to their needs and those of their patients, for optimal use and safety.

Through its network of 26 subsidiaries and 400 distributors, Vygon distributes over 205 million products a year in more than 120 countries. Its products display the CE and/or FDA mark and are manufactured in the group’s eleven factories in Europe, the US and Colombia.

Vygon is a family company founded in 1962, based in Ecouen, in France’s Greater Paris region. It is a mid-sized business employing over 2,700 staff worldwide. The turnover in 2024 was €417.9 million, with 81% of this derived from Vygon’s international business.

www.vygon.com